Sagility LLC Acquires Healthcare Analytics Firm Careseed in US$30 Million Deal
Sagility LLC, a step-down subsidiary of Sagility Limited, has acquired Careseed LLC, expanding its capabilities within the healthcare analytics and technology sector. The definitive agreement for the acquisition was signed on June 11, 2026.The transaction is designed to strengthen Sagility's strategic position in providing healthcare analytics services, particularly focusing on quality measurement and risk adjustment solutions. By acquiring Careseed, Sagility gains a proven, NCQA certified HEDIS reporting platform and access to a base of 30 mid-sized U.S. health plans. This move allows Sagility to expand into STAR performance management and care gap closure services, creating opportunities for cross-selling integrated technology and service offerings to drive improved quality outcomes for clients in the payer ecosystem.
Careseed LLC operates within the USA Healthcare analytics and technology industry. The acquisition involves a cash consideration structure with an aggregate purchase consideration of up to US$ 30 million. This total cost includes an upfront payment of US$ 17.5 million, subject to customary closing adjustments, and a contingent consideration of up to US$ 12.5 million, which is payable upon achievement of Revenue Growth synergies.
Careseed LLC was incorporated in 2012 and is based in Kansas City, United States. The company provides an NCQA certified cloud-based platform that offers solutions for HEDIS reporting, medical record review, and quality analytics, alongside related value-added services to U.S. health plans.
Details regarding the acquired entity and the transaction are summarized below:
| Particulars | Details |
|---|---|
| Target Entity | Careseed LLC (Turnover CY2025: US$ 5.1M) |
| Industry | USA Healthcare analytics and technology |
| Acquisition Status | No related party transaction |
| Consideration Type | Cash |
| Purchase Consideration | Aggregate up to US$ 30 million |
| Upfront Payment | US$ 17.5 Million |
| Contingent Consideration | Up to US$ 12.5 Million (linked to Revenue Growth synergies) |
| Shareholding Acquired | 100% |
Careseed LLC reported turnovers of approximately USD 3.6 million in CY2023, USD 4.0 million in CY2024, and USD 5.1 million for CY2025. The acquisition is indicative of a strategy shift to expand Sagility's influence within the payer ecosystem by securing advanced analytics capabilities.
SAGILITY Stock Price Movement
Shares of SAGILITY LIMITED today slipped by 1.87% to settle at ₹39.26, having shed ₹0.75 in post-market trading. The equity saw strong investor interest as it closed, with 7.78 million shares traded during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.